Van Eck Associates Corp Amgen Inc Transaction History

Van Eck Associates Corp

$80.1 Billion
Q3 2024

A detailed history of Van Eck Associates Corp transactions in Amgen Inc stock. As of the latest transaction made, Van Eck Associates Corp holds 285,446 shares of AMGN stock, worth $84.1 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

285,446

Previous 266,873 6.96%

Holding current value

$84.1 Million

Previous $83.4 Million 7.8%

% of portfolio

0.11%

Previous 0.12%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	BUY	$309.38 - $337.38 $5.75 Million - $6.27 Million	18,573 Added 6.96%	285,446 $89.9 Million
Q2 2024 Jul 31, 2024	SELL	$262.75 - $319.31 $239,365 - $290,891	-911 Reduced 0.34%	266,873 $83.4 Million
Q1 2024 Apr 30, 2024	SELL	$268.87 - $324.56 $15.1 Million - $18.2 Million	-56,033 Reduced 17.3%	267,784 $76.1 Million
Q4 2023 Feb 05, 2024	SELL	$255.7 - $288.46 $153 Million - $173 Million	-599,315 Reduced 64.92%	323,817 $93.3 Million
Q3 2023 Nov 08, 2023	BUY	$218.65 - $271.46 $14.5 Million - $18 Million	66,399 Added 7.75%	923,132 $248 Million
Q2 2023 Aug 03, 2023	BUY	$214.27 - $253.37 $121 Million - $143 Million	565,032 Added 193.7%	856,733 $190 Million
Q1 2023 May 03, 2023	BUY	$225.79 - $275.2 $4.8 Million - $5.85 Million	21,269 Added 7.86%	291,701 $70.5 Million
Q4 2022 Feb 08, 2023	SELL	$229.03 - $291.01 $7.95 Million - $10.1 Million	-34,705 Reduced 11.37%	270,432 $71 Million
Q3 2022 Oct 27, 2022	BUY	$224.46 - $253.15 $5.91 Million - $6.67 Million	26,346 Added 9.45%	305,137 $68.8 Million
Q2 2022 Aug 03, 2022	SELL	$230.71 - $256.74 $2.41 Million - $2.68 Million	-10,433 Reduced 3.61%	278,791 $67.8 Million
Q1 2022 May 10, 2022	SELL	$219.27 - $242.57 $5.91 Million - $6.54 Million	-26,971 Reduced 8.53%	289,224 $69.9 Million
Q4 2021 Jan 26, 2022	BUY	$198.88 - $227.6 $12.1 Million - $13.8 Million	60,606 Added 23.71%	316,195 $71.1 Million
Q3 2021 Nov 03, 2021	BUY	$212.27 - $248.7 $5.33 Million - $6.25 Million	25,117 Added 10.9%	255,589 $54.4 Million
Q2 2021 Aug 10, 2021	SELL	$233.58 - $259.14 $7.04 Million - $7.81 Million	-30,120 Reduced 11.56%	230,472 $56.2 Million
Q1 2021 May 13, 2021	SELL	$221.91 - $258.6 $12.9 Million - $15.1 Million	-58,314 Reduced 18.29%	260,592 $64.8 Million
Q4 2020 Feb 09, 2021	SELL	$216.38 - $257.67 $2.75 Million - $3.27 Million	-12,705 Reduced 3.83%	318,906 $73.3 Million
Q3 2020 Nov 12, 2020	SELL	$234.65 - $260.95 $7.29 Million - $8.11 Million	-31,064 Reduced 8.57%	331,611 $84.3 Million
Q2 2020 Aug 10, 2020	BUY	$197.81 - $242.74 $21.7 Million - $26.7 Million	109,870 Added 43.46%	362,675 $85.5 Million
Q1 2020 May 12, 2020	SELL	$182.24 - $241.7 $35.2 Million - $46.7 Million	-193,156 Reduced 43.31%	252,805 $51.3 Million
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $20 Million - $25.7 Million	-105,856 Reduced 19.18%	445,961 $108 Million
Q3 2019 Nov 08, 2019	BUY	$174.11 - $208.62 $28.2 Million - $33.8 Million	161,824 Added 41.49%	551,817 $107 Million
Q2 2019 Aug 07, 2019	BUY	$166.7 - $195.41 $29.6 Million - $34.7 Million	177,726 Added 83.73%	389,993 $71.9 Million
Q1 2019 May 13, 2019	BUY	$180.87 - $203.88 $2.21 Million - $2.49 Million	12,212 Added 6.1%	212,267 $40.3 Million
Q4 2018 Feb 12, 2019	SELL	$178.4 - $208.25 $20.5 Million - $24 Million	-115,096 Reduced 36.52%	200,055 $38.9 Million
Q3 2018 Nov 13, 2018	SELL	$185.29 - $208.89 $22.7 Million - $25.6 Million	-122,344 Reduced 27.96%	315,151 $65.3 Million
Q2 2018 Aug 13, 2018	SELL	$166.05 - $186.51 $6.69 Million - $7.51 Million	-40,271 Reduced 8.43%	437,495 $80.8 Million
Q1 2018 May 11, 2018	SELL	$169.43 - $198.0 $16.7 Million - $19.6 Million	-98,775 Reduced 17.13%	477,766 $81.5 Million
Q4 2017 Feb 12, 2018	BUY	$168.79 - $188.59 $1.13 Million - $1.27 Million	6,708 Added 1.18%	576,541 $100 Million
Q3 2017 Nov 09, 2017	SELL	$167.29 - $191.0 $11.4 Million - $13 Million	-68,303 Reduced 10.7%	569,833 $106 Million
Q2 2017 Aug 11, 2017	BUY	N/A	638,136	638,136 $110 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $158B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.

Account

Van Eck Associates Corp Amgen Inc Transaction History